CSIMarket
 


Fibrogen Inc   (FGEN)
Other Ticker:  
 
 

FGEN's Free Cash Flow Growth by Quarter and Year

Fibrogen Inc 's Free Cash Flow results by quarter and year




FGEN Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -52.51 -54.96 -1.35
III Quarter September -84.54 -51.88 44.26 149.67
II Quarter June -110.57 -33.06 -26.54 -59.49
I Quarter March -101.59 -8.48 -44.98 -45.05
FY   -296.70 -145.93 -82.22 43.78



FGEN Free Cash Flow third quarter 2023 Y/Y Growth Comment
Fibrogen Inc in the third quarter 2023 recorded free cash outflow of $ -84.54 millions.

According to the results reported in the third quarter 2023, Fibrogen Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Fibrogen Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




FGEN Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - -70.43 % -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Fibrogen Inc 's third quarter 2023 Free Cash Flow $ -84.54 millions FGEN's Income Statement
Fibrogen Inc 's third quarter 2022 Free Cash Flow $ -51.88 millions Quarterly FGEN's Income Statement
New: More FGEN's historic Free Cash Flow Growth >>


FGEN Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Fibrogen Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FGEN's III. Quarter Q/Q Free Cash Flow Comment
Although Fibrogen Inc in the III. Quarter 2023 showed free cash outflow of $ -84.54 millions, it should be point out, that this are slight up side compare to the -110.57 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Fibrogen Inc achieved highest sequential Free Cash Flow growth. While Fibrogen Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FGEN's III. Quarter Q/Q Free Cash Flow Comment
Even if Fibrogen Inc in the III. Quarter 2023 admitted free cash outflow of $ -84.54 millions, management mentioned, that those numbers point to slight up side relative to the -110.57 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Fibrogen Inc achieved highest sequential Free Cash Flow growth. While Fibrogen Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Fibrogen Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ -346.61 $ -313.77 $ -236.35 $ -142.19 $ -143.58
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Fibrogen Inc ' has realized cumulative trailing twelve months free cash outflow of $ -347 millions in the Sep 30 2023 period.
The business is detiriorating as the cumulative free cash outflow is inflating from $ -313.77 millions for the period from Jun 30 2023 to Sep 30 2022 and $ -46.731 millions from the TTM period ending Sep 30 2022.

Fibrogen Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Fibrogen Inc ' has realized cumulative trailing twelve months free cash outflow of $ -347 millions in the Sep 30 2023 period.
The results are detiriorating as the cumulative free cash outflow is inflating from $ -313.77 millions in the twelve months ending a quarter before and $ -46.731 millions for the twelve months ending in the quarter Sep 30 2022 Daniel  Wood told.

Fibrogen Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
FGEN's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for FGEN's Competitors
Free Cash Flow Growth for Fibrogen Inc 's Suppliers
Free Cash Flow Growth for FGEN's Customers

You may also want to know
FGEN's Annual Growth Rates FGEN's Profitability Ratios FGEN's Asset Turnover Ratio FGEN's Dividend Growth
FGEN's Roe FGEN's Valuation Ratios FGEN's Financial Strength Ratios FGEN's Dividend Payout Ratio
FGEN's Roa FGEN's Inventory Turnover Ratio FGEN's Growth Rates FGEN's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Envista Holdings Corporation104.50%$ 104.497 millions
Veracyte Inc 101.69%$ 101.694 millions
Msa Safety Inc95.20%$ 95.198 millions
Halozyme Therapeutics Inc 90.15%$ 90.150 millions
Artivion Inc 81.89%$ 81.891 millions
Tactile Systems Technology Inc 81.72%$ 81.721 millions
Conmed Corporation78.14%$ 78.145 millions
Bausch and Lomb Corp77.78%$ 77.778 millions
Regeneron Pharmaceuticals Inc 77.18%$ 77.182 millions
Vericel Corporation74.81%$ 74.811 millions
Viemed Healthcare Inc 73.22%$ 73.219 millions
Collegium Pharmaceutical inc 73.06%$ 73.065 millions
Teladoc Health Inc 67.56%$ 67.565 millions
Lemaitre Vascular Inc 61.03%$ 61.032 millions
Enovis Corp59.78%$ 59.778 millions
Tenet Healthcare Corp59.68%$ 59.683 millions
Corcept Therapeutics Inc57.24%$ 57.243 millions
Charles River Laboratories International inc 54.73%$ 54.731 millions
Hologic Inc53.44%$ 53.440 millions
Globus Medical Inc 53.35%$ 53.354 millions
The Pennant Group Inc 53.28%$ 53.276 millions
Boston Scientific Corporation48.51%$ 48.511 millions
Shockwave Medical Inc 46.87%$ 46.866 millions
Idexx Laboratories Inc44.14%$ 44.144 millions
Merit Medical Systems Inc43.90%$ 43.901 millions
Intuitive Surgical Inc 43.11%$ 43.111 millions
Endo International Plc42.44%$ 42.438 millions
Steris Plc40.71%$ 40.714 millions
Privia Health Group Inc 39.12%$ 39.120 millions
Merck and Co Inc 37.75%$ 37.754 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com